Showing results (141-150 of 517) with videos related to
Sort By:
Pageof 52
Journal of Thrombosis and Haemostasis : JTH|October 15, 2010
The prothrombin time/international normalized ratio (PT/INR) Line: derivation of local INR with commercial thromboplastins and coagulometers--two independent studiesL Poller, S Ibrahim, M Keown, et al.British Journal of Haematology|November 1, 1976
Abnormal fibrin polymerization in liver diseaseG Green, J M Thomson, I W Dymock, et al.Lancet (London, England)|June 14, 1975
Use of factor-VII-rich prothrombin complex concentrate in liver diseaseG Green, I W Dymock, L Poller, et al.British Heart Journal|April 1, 1990
Reduction of factor VII coagulant activity (VIIC), a risk factor for ischaemic heart disease, by fixed dose warfarin: a double blind crossover studyL Poller, P K MacCallum, J M Thomson, et al.Journal of Clinical Pathology|November 1, 1976
Factor VII as a marker of hepatocellular synthetic function in liver diseaseG Green, L Poller, J M Thomson, et al.Journal of Clinical Pathology|October 1, 1971
Identification of a congenital defect of factor VII in a colony of beagle dogs: the clinical use of the plasmaL Poller, J M Thomson, C H Sear, et al.Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement|January 1, 1983
Hemoperfusion with chelating microspheres as a new treatment for severe mercury poisoningS Margel, J Hirsh, I HarariAnnual Review of Medicine|April 25, 2000
Management of patients with hereditary hypercoagulable disordersC Kearon, M Crowther, J HirshThe Journal of Biological Chemistry|June 11, 1998
Cholecystokinin decreases intestinal hexose absorption by a parallel reduction in SGLT1 abundance in the brush-border membraneA J Hirsh, C I CheesemanThe American Journal of Medicine|September 11, 1989
Congenital antithrombin III deficiency. Incidence and clinical featuresJ Hirsh, F Piovella, M PiniPageof 52